Intralesional interleukin-2 for unresectable mucosal melanoma refractory to nivolumab
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Immunotherapy | Melanoma | Skin Cancer